Explorer les evidences

90 %The HPV vaccination program in Rwanda achieved over 90% coverage for girls aged 12.

Rwandainfection à HPVAfrica CDCdocument de 52 observations

0,8 %The point-prevalence of eczema was 0.8% in Rwanda.

Rwandaeczemapublié 2012Journal of the European Academy of Dermatology and Venereology : JEADVeurope_pmcdocument de 10 observations

11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.

Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobservé February 2025Africa CDCdocument de 110 observations

500 peopleRwanda vaccinated approximately 500 people in Africa’s first mpox vaccination campaign, launched on 17 September 2024.

Rwandampoxobservé 17 September 2024Africa CDCdocument de 147 observations

26,7 %The overall prevalence of schoolchildren with any skin disease was 26.7% in Rwanda.

Rwandaskin diseasepublié 2013International journal of dermatologyeurope_pmcdocument de 8 observations

22,7 %Skin infections accounted for 22.7% of skin disease in Rwanda.

Rwandaskin infectionpublié 2013International journal of dermatologyeurope_pmcdocument de 8 observations

12 220 childrenThe estimated sample size for parasite prevalence in the 2014–2015 Rwanda Demographic and Health Survey (DHS) was 12,220 children aged 0–4 years.

Rwandapaludismeobservé 2014-2015publié 2017Malaria journaleurope_pmcdocument de 4 observations

Rwanda aims to achieve the 90-70-90 cervical cancer elimination targets by 2027.

Rwandacancer du col de l'utérusobservé 2027Africa CDCdocument de 52 observations

50 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Rwanda était de 50 % dans une étude cohorte et transversale populationnelle.

Rwandaneuropathie périphériqueobservé 2014HAL · Unilimdocument de 747 observations

308 casesIn Rwanda, there were 308 cholera cases and 0 deaths from March 2025 to July 2025.

Rwandacholéraobservé Mar 2025 – 31 July 2025Africa CDCdocument de 176 observations

0 deathsRwanda reported 0 cholera deaths, with the outbreak starting in March 2025.

Rwandacholéraobservé Mar 2025Africa CDCdocument de 176 observations

88 %In Rwanda, 88% of cholera cases were among children under 15 years old.

Rwandacholéraobservé Mar 2025 – 31 July 2025Africa CDCdocument de 176 observations

6 269 dosesAs of 27 January 2025, 6,269 mpox vaccine doses had been administered in Rwanda.

Rwandampoxobservé 27 January 2025Africa CDCdocument de 72 observations

308 casesRwanda reported 308 cholera cases and 0 deaths, with the outbreak starting in March 2025.

Rwandacholéraobservé Mar 2025Africa CDCdocument de 176 observations

90 %Rwanda is focusing on advancing efforts toward the 90% cervical cancer treatment target.

Rwandacancer du col de l'utérusAfrica CDCdocument de 52 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic and Nigeria — are currently vaccinating against mpox.

Nigeria · Ouganda · RDC · Rwandampoxobservé January-February 2025Africa CDCdocument de 72 observations

500 peopleRwanda conducted a vaccination campaign in the last week of September 2024, vaccinating approximately 500 people.

Rwandampoxobservé last week of September 2024Africa CDCdocument de 147 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — were vaccinating against mpox during January–February 2025.

Nigeria · Ouganda · RDC · Rwandampoxobservé January-February 2025Africa CDCdocument de 72 observations

59 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Rwanda était de 59 % en 2014.

RwandaVIH/sidaobservé 2014HAL · Unilimdocument de 747 observations

Rwanda had the second-lowest age-standardised prevalence of diabetes for men.

Rwandadiabète (non précisé)HAL · Unilimdocument de 79 observations

22 districtsHPV DNA testing was introduced in Rwanda in 2019 and extended screening to 22 of 30 districts.

Rwandainfection à HPVobservé 2019Africa CDCdocument de 52 observations

Burundi, Central African Republic, Congo, Democratic Republic of the Congo, Gabon, Kenya, Rwanda, and Uganda reported mpox cases belonging to Clade I.

Burundi · Gabon · Kenya · Ouganda · RDC · RwandaClade I · mpoxAfrica CDCdocument de 11 observations

3,2 %La prévalence du diabète gestationnel au Rwanda était de 3,2 %.

Rwandadiabète gestationnelHAL · Unilimdocument de 602 observations

70 %Rwanda is focusing on advancing efforts toward the 70% cervical cancer screening target.

Rwandacancer du col de l'utérusAfrica CDCdocument de 52 observations

18 casesGenomic analysis of samples from 18 cases of Marburg virus disease was conducted in Rwanda.

RwandaMarburg virus diseasepublié 2025Nature medicineeurope_pmcdocument de 4 observations